Who Exports Brufen from India — 140 Suppliers Behind a $4.5M Market
India's brufen export market is supplied by 140 active exporters who collectively shipped $4.5M across 1,838 shipments. MYLAN LABORATORIES LIMITED leads with a 55.0% market share, followed by GELTEC PRIVATE LIMITED and ABBOTT INDIA LIMITED. The top 5 suppliers together control 94.3% of total export value, reflecting a concentrated market structure.
Top Brufen Exporters from India — Ranked by Export Value
MYLAN LABORATORIES LIMITED is the leading brufen exporter from India, holding a 55.0% share of the $4.5M market across 1,838 shipments from 140 exporters. The top 5 suppliers — MYLAN LABORATORIES LIMITED, GELTEC PRIVATE LIMITED, ABBOTT INDIA LIMITED, MEDREICH LIMITED, RIZOCHEM PHARMACEUTICALS — collectively control 94.3% of total export value, indicating a highly concentrated market. Individual shares are: MYLAN LABORATORIES LIMITED (55.0%), GELTEC PRIVATE LIMITED (22.2%), ABBOTT INDIA LIMITED (9.2%), MEDREICH LIMITED (4.6%), RIZOCHEM PHARMACEUTICALS (3.3%).
Top Brufen Exporters from India
Ranked by export value · 140 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED BRUFEN 400 TABLETS X 100 PACKS 60960BRUFEN 400 TABLETS X 100 PACKS 61143BRUFEN RAPID 400MG 1X10CAPS UA | $2.5M | 1 | 55.0% |
| 2 | GELTEC PRIVATE LIMITED BRUFEN 400 TABLETS X 100 PACKS 60960BRUFEN 400 TABLETS X 100 PACKS 61143BRUFEN RAPID 400MG 1X10CAPS UA | $994.9K | 1 | 22.2% |
| 3 | ABBOTT INDIA LIMITED BRUFEN 400 MG TABLET 15 SBRUFEN 400 MG TABLET 15'SBRUFEN JR SYRUP 60 ML IBUPROFEN ORAL SUSPENSION B.P. | $414.4K | 4 | 9.2% |
| 4 | MEDREICH LIMITED IBUPROFEN 400MG TABLETS 3X10SIBUPROFEN 400MG TABLETS (IBRUFENO IN PHAIBUPROFEN 400MG TABLETS 3X10S NOS | $206.3K | 3 | 4.6% |
| 5 | RIZOCHEM PHARMACEUTICALS | $147.6K | 1 | 3.3% |
| 6 | HEMS ( INDIA ) BRUFEN 200MG TABSBRUFEN 400MG TAB 20SBRUFEN 400 MG TABLET 15 S | $45.5K | 1 | 1.0% |
| 7 | D VIJAY PHARMA PVT LTD BRUFEN 400 TABLETS X 100 PACKS 60960BRUFEN 400 TABLETS X 100 PACKS 61143BRUFEN RAPID 400MG 1X10CAPS UA | $21.9K | 1 | 0.5% |
| 8 | ALPHA BIOCEUTICALS | $13.5K | 1 | 0.3% |
| 9 | AASHIRWAD PHARMA INTERNATIONAL PRIVATE LIMITED BRUFEN 400MGBRUFEN 400MG TABIBUPROFEN 600MG TABLETS BRUFEN 600 TAB | $12.8K | 6 | 0.3% |
| 10 | VEA IMPEX (I) PRIVATE LIMITED BRUFEN 200MG TABSBRUFEN 400MG TAB IBUPROFENBRUFEN 400MG TABS | $9.3K | 6 | 0.2% |
| 11 | CAPSTONE EXPORT & IMPORT BRUFEN 400MG TAB IBUPROFENBRUFEN 400MG TABSPHARMACEUTICAL AND HEALTHCARE PRODUCT:BRUFEN 400MG | $8.5K | 1 | 0.2% |
| 12 | TRIKAYA GLOBAL BRUFEN 400MG TAB IBUPROFENBRUFEN 400MG TABSBRUFEN 400MG | $8.4K | 2 | 0.2% |
| 13 | GET EXPORTS & IMPORTS SHOP BRUFEN 200MG TABSBRUFEN 400MG TAB 20SBRUFEN 400 MG TABLET 15 S | $8.1K | 1 | 0.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Brufen exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| MYLAN LABORATORIES LIMITED | Approved | Yes | Yes | Not verified | Mylan Laboratories Limited holds FDA approval, WHO-GMP, and EU GMP certification |
| MEDREICH LIMITED | Not Listed | Yes | Yes | Not verified | Medreich Limited is certified with WHO-GMP and EU GMP standards. |
| GELTEC PRIVATE LIMITED | Not Listed | Yes | Not Listed | Not verified | Geltec Private Limited holds WHO-GMP certification. |
| ABBOTT INDIA LIMITED | Not Listed | Yes | Not Listed | Not verified | Abbott India Limited is certified with WHO-GMP standards. |
| HEMS (INDIA) | Not Listed | Yes | Not Listed | Not verified | HEMS (India) holds WHO-GMP certification. |
| D VIJAY PHARMA PVT LTD | Not Listed | Yes | Not Listed | Not verified | D Vijay Pharma Pvt Ltd is certified with WHO-GMP standards. |
| ALPHA BIOCEUTICALS | Not Listed | Yes | Not Listed | Not verified | Alpha Bioceuticals holds WHO-GMP certification. |
| AASHIRWAD PHARMA INTERNATIONAL PRIVATE LIMITED | Not Listed | Yes | Not Listed | Not verified | Aashirwad Pharma International Private Limited is certified with WHO-GMP standar |
TransData Nexus reviewed the regulatory standing of 8 leading Brufen exporters from India. 1 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 2 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Brufen sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for the production of active pharmaceutical ingredients (APIs). The city hosts over 2,000 life sciences companies and contributes to approximately 40% of India's pharmaceutical production. This extensive infrastructure supports the manufacturing of APIs essential for formulations like Brufen. The presence of numerous USFDA-approved facilities underscores Hyderabad's capacity to meet international quality standards, making it a critical node in the global supply chain for ibuprofen APIs.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to leading companies such as Alembic Pharmaceuticals and Zydus Lifesciences, which specialize in producing finished dosage forms. The cluster's well-established infrastructure and proximity to major ports facilitate efficient export operations. Given that Brufen is a widely used formulation, the capabilities of this hub are instrumental in meeting both domestic and international demand.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products. With its strategic location and access to major ports, this cluster enables seamless international distribution. Companies like Sun Pharmaceutical Industries Limited, headquartered in Mumbai, leverage this advantage to export formulations such as Brufen to various global markets. The region's robust regulatory framework and compliance with international standards further enhance its role in the global pharmaceutical supply chain.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives. This cluster hosts numerous manufacturing units that produce a wide range of pharmaceutical products, including ibuprofen formulations. The cost advantages associated with this region make it an attractive destination for companies aiming to optimize production expenses while maintaining quality standards.
5Sourcing Recommendations
- Diversify Supplier Base: To mitigate risks associated with supplier concentration, consider engaging with multiple manufacturers across different clusters, such as those in Hyderabad for APIs and Ahmedabad-Vadodara for formulations.
- Leverage Export Infrastructure: Utilize the export capabilities of the Mumbai-Thane-Raigad cluster to facilitate efficient international distribution of Brufen.
- Optimize Cost Structures: Explore partnerships with manufacturers in the Baddi-Nalagarh region to take advantage of tax incentives and reduce production costs.
- Ensure Regulatory Compliance: Prioritize suppliers with USFDA-approved facilities to guarantee adherence to international quality standards, thereby enhancing market acceptance and reducing regulatory hurdles.
By strategically engaging with these pharmaceutical clusters, TransData Nexus can enhance its supply chain resilience and optimize the sourcing and distribution of Brufen.
Common Questions — Brufen Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which brufen supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MYLAN LABORATORIES LIMITED leads with 35 recorded shipments worth $2.5M. GELTEC PRIVATE LIMITED (42 shipments) and ABBOTT INDIA LIMITED (89 shipments) are also established high-volume exporters.
Q How many brufen manufacturers are there in India?
India has 140 active brufen exporters with a combined export market of $4.5M across 1,838 shipments to 78 countries. The top 5 suppliers hold 94.3% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for brufen from India?
Average FOB unit price: $1.85 per unit, ranging from $0.01 to $95.05. Average shipment value: $2.4K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 140 verified Indian exporters of Brufen ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,838 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 78 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,838 Verified Shipments
140 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists